EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases

Tara Fiyouzi iD, Hector F Pelaez-Prestel iD, Raquel Reyes-Manzanas iD, Esther M Lafuente iD, Pedro A Reche iD

International Journal of Molecular Sciences · 25.04.2023 · 24 (9) · 7797

DOI: 10.3390/ijms24097797 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.04.2023. Verfasst von Tara Fiyouzi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunomedicine, Faculty of Medicine, University Complutense of Madrid, Ave Complutense S/N, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Autoimmune Diseases. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T cells (Tregs) control immune responses and are essential to maintain immune homeostasis and self-tolerance. Hence, it is no coincidence that autoimmune and chronic inflammatory disorders are associated with defects in Tregs. These diseases have currently no cure and are treated with palliative drugs such as immunosuppressant and immunomodulatory agents. Thereby, there is a great interest in developing medical interventions against these diseases based on enhancing Treg cell function and numbers. Here, we give an overview of Treg cell ontogeny and function, paying particular attention to mucosal Tregs. We review some notable approaches to enhance immunomodulation by Tregs with therapeutic purposes including adoptive Treg cell transfer therapy and discuss relevant clinical trials for inflammatory bowel disease. We next introduce ways to expand mucosal Tregs in vivo using microbiota and dietary products that have been the focus of clinical trials in various autoimmune and chronic-inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryAutoimmune DiseasesHumansImmune ToleranceImmunotherapy, AdoptiveImmunomodulation

Stichwörter der Autor:innen

SCFAadoptive Treg cell transferautoimmune diseaseinflammatory bowel diseasemicrobiotamucosal immunitymucosal toleranceregulatory T cellsvitamin D3

Autor:innen und Institutionen

  • Laboratory of Immunomedicine, Faculty of Medicine, University Complutense of Madrid, Ave Complutense S/N, 28040 Madrid, Spain.

ORCID-Profile: Tara Fiyouzi, Hector F Pelaez-Prestel, Raquel Reyes-Manzanas, Esther M Lafuente, Pedro A Reche

Zitieren

APA

Fiyouzi, T., Pelaez-Prestel, H. F., Reyes-Manzanas, R., Lafuente, E. M., & Reche, P. A. (2023). Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases. International Journal of Molecular Sciences, 24(9), 7797. https://doi.org/10.3390/ijms24097797

Vancouver

Fiyouzi T, Pelaez-Prestel HF, Reyes-Manzanas R, Lafuente EM, Reche PA. Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases. International Journal of Molecular Sciences. 2023;24(9):7797. doi:10.3390/ijms24097797

BibTeX
@article{Fiyouzi2023,
  author = {Fiyouzi, Tara and Pelaez-Prestel, Hector F and Reyes-Manzanas, Raquel and Lafuente, Esther M and Reche, Pedro A},
  title = {Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {7797},
  doi = {10.3390/ijms24097797}
}
Kostenlos starten →